Researchers from the University of Salerno, Italy, have found that a simple blood test for tTG-IgA concentrations could be used as a diagnostic threshold in predicting duodenal villous atrophy, a hallmark of celiac disease.
Though oral health issues can affect overall health, the two are considered unrelated and are frequently addressed separately when it comes to treatment. However, existing research shows that patients with inflammatory bowel ...
Wheat, barley and rye contain a protein that can produce severe intestinal symptoms in people with celiac disease, and a team of scientists at Columbia University in New York has now identified distinct signatures of immune ...
Research led by the People's Hospital of Zhengzhou University, China, has found a connection between gut microbiota and distal symmetric polyneuropathy. In a paper, "Gut microbiota modulate distal symmetric polyneuropathy ...
A genomic study led by researchers at Stanford University, California, has performed ultra-deep metagenomic sequencing on 351 fecal samples from the Hadza hunter-gatherers of Tanzania. In their paper, "Ultra-deep sequencing ...
A large team of cancer researchers affiliated with multiple institutions in Germany, working with a colleague from the U.S., has discovered some of the ways gut bacteria can positively impact treatments for cancer. In their ...
An altered gut microbiome is an unexpected cause of fever afflicting many patients undergoing chemotherapy, according to scientists who've also discovered that poor appetite during cancer treatment may trigger the biological ...
A study of patients with a chronic intestinal condition has helped demystify—but not totally solve—a puzzling disorder that is widespread in low-and middle-income countries, but is largely unseen in wealthier regions ...
Disruptions in the gut microbiome have been linked to lower survival rates for people who have undergone kidney and liver transplants, a finding that highlights the critical importance of the vast and complex microbial communities ...
A team of researchers at the Max Planck Institute for Immunobiology and Epigenetics, working with colleagues from the Washington University School of Medicine, the Medical University of Vienna, the Van Andel Research Institute ...
